leading to a stronger core business structure. Analyst Brian Abrahams believes Biogen’s stock is undervalued compared to its actual business fundamentals. He suggests that progress with Leqembi ...

She is the lead author of a new study that estimated the amount of time people might continue to perform daily activities without assistance after beginning lecanemab, marketed as Leqembi ...

A monoclonal antibody called Leqembi (lecanemab) has been approved by the Food and ... Participation in cognitively-stimulating activities is associated with brain structure and cognitive function in ...

New York, USA, March 03, 2025 (GLOBE NEWSWIRE) -- LEQEMBI Market Sales Reflect Growing Confidence in Disease-Modifying Alzheimer’s Treatments| DelveInsight LEQEMBI (lecanemab) has significant ...

The company confirmed this morning that NICE has taken the "unusual decision" to hold a third appraisal committee meeting as part of its ongoing evaluation of Leqembi (lecanemab), which was turned ...

New York, USA, March 03, 2025 (GLOBE NEWSWIRE) -- LEQEMBI Market Sales Reflect Growing Confidence in Disease-Modifying Alzheimer’s Treatments| DelveInsight LEQEMBI (lecanemab) has significant market ...

For Eisai and Biogen, the CHMP’s decision to stick by its previous call now punts the final approval verdict for Leqembi back to the European Commission (EC), which is the ultimate authority on ...